Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies.

Libutti, S K; Barlett, D L; Fraker, D L; Alexander, H R

Libutti, S K; Barlett, D L; Fraker, D L; Alexander, H R.

Affiliation

Libutti SK; Surgical Metabolism Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1502, USA.

J Am Coll Surg ; 191(5): 519-30, 2000 Nov.

Article in En | MEDLINE | ID: mdl-11085732

Subject(s)

Antineoplastic Agents, Alkylating/administration & dosage; Chemotherapy, Cancer, Regional Perfusion; Hyperthermia, Induced; Liver Neoplasms/therapy; Melphalan/administration & dosage; Tumor Necrosis Factor-alpha/administration & dosage; Adult; Aged; Antineoplastic Agents, Alkylating/adverse effects; Chemotherapy, Cancer, Regional Perfusion/adverse effects; Chemotherapy, Cancer, Regional Perfusion/methods; Female; Humans; Hyperthermia, Induced/adverse effects; Liver Neoplasms/secondary; Male; Melphalan/adverse effects; Middle Aged; Serum Albumin, Radio-Iodinated/administration & dosage; Tumor Necrosis Factor-alpha/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chemotherapy, Cancer, Regional Perfusion / Tumor Necrosis Factor-alpha / Antineoplastic Agents, Alkylating / Hyperthermia, Induced / Liver Neoplasms / Melphalan Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Surg Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links